Actoxumab, CAS 1245634-25-6

Product Description: Actoxumab (Anti-C. difficile Toxin A Recombinant Antibody) is a antitoxin antibody against C. difficile toxin A by neutralizing TcdA. Actoxumab prevents both the damage to the gut wall and the inflammatory response, which are associated with C. difficile. Actoxumab has synergy effect with Bezlotoxumab (HY-P9929) targeting TcdB[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Yang Z, et al. Mechanisms of protection against Clostridium difficile infection by the monoclonal antitoxin antibodies actoxumab and bezlotoxumab. Infect Immun. 2015 Feb;83(2):822-31.

CAS Number: 1245634-25-6

Molecular Weight: 145.9 (kDa)

Compound Purity: 99.52

Research Area: Infection

Solubility: 10 mM in DMSO

Target: Others

• Artikelnummer: MEXHY-P99277-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99277-5
• Green Labware: Nein
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK